Guozhong Jiang

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Venues

Journal of hepatocellular carcinoma

Cancer cell international

Cancer management and research

Journal of translational medicine

First Affiliated Hospital of Zhengzhou University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

First Affiliated Hospital of Zhengzhou University

China

Dr. :: Pathology

Publications

Yuyuan Zhang, Zaoqu Liu, Jie Li, Xin Li, Mengjie Duo, Siyuan Weng, Peijie Lv, Guozhong Jiang, Caihong Wang, Yan Li, Shichao Liu, Zhen Li
Prognosis and Personalized Treatment Prediction in Different Mutation-Signature Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 10 (2023)
Yuyuan Zhang, Zaoqu Liu, Jie Li, Xin Li, Mengjie Duo, Siyuan Weng, Peijie Lv, Guozhong Jiang, Caihong Wang, Yan Li, Shichao Liu, Zhen Li
Prognosis and Personalized Treatment Prediction in Different Mutation-Signature Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 10 (2023)
Shuiling Jin, Ruihua Zhao, Chuang Zhou, Qian Zhong, Jianxiang Shi, Chang Su, Qinglong Li, Xiaoxing Su, Huabin Chi, Xu Lu, Guozhong Jiang, Renyin Chen, Jinming Han, Miao Jiang, Shishi Qiao, Jingjing Liu, Min Song, Lijie Song, Yabing Du, Zhiwei Chang, Meng Wang, Meilian Dong, Yali Zhong, Pu Yu, Xiaojian Zhang, Hong Zong
Feasibility and tolerability of sintilimab plus anlotinib as the second-line therapy for patients with advanced biliary tract cancers: An open-label, single-arm, phase II clinical trial. International journal of cancer (2022)
Junkuo Li, Pan Li, Jia Li, Haijun Yang, Guohua Liu, Peihong Shen, Guozhong Jiang
Effects of the Methylation Levels for the Breast Cancer Associated Genes BCSG1 and BRCA1 on Cellular Proliferation and Migration. Genetic testing and molecular biomarkers 26 (9) (2022)
Weiwei Wang, Di Zhu, Zhihua Zhao, Miaomiao Sun, Feng Wang, Wencai Li, Jianying Zhang, Guozhong Jiang
RNA sequencing reveals the expression profiles of circRNA and identifies a four-circRNA signature acts as a prognostic marker in esophageal squamous cell carcinoma. Cancer cell international 21 (1) (2021)
Peiyi Xia, Lan Zhang, Pan Li, Enjie Liu, Wencai Li, Jianying Zhang, Hui Li, Xiaoxing Su, Guozhong Jiang
Molecular characteristics and clinical outcomes of complex ALK rearrangements identified by next-generation sequencing in non-small cell lung cancers. Journal of translational medicine 19 (1) (2021)
Meiying Cui, Pan Li, Ying Mao, Lan Zhang, Peiyi Xia, Enjie Liu, Weiwei Wang, Jianying Zhang, Guozhong Jiang, Wencai Li
Implication of Microsatellite Instability in Chinese Cohort of Human Cancers. Cancer management and research 12 (2020)
Meiying Cui, Yuchen Han, Pan Li, Jianying Zhang, Qiuxiang Ou, Xiaoling Tong, Ruiying Zhao, Nan Dong, Xue Wu, Wencai Li, Guozhong Jiang
Molecular and clinicopathological characteristics of ROS1-rearranged non-small-cell lung cancers identified by next-generation sequencing. Molecular oncology 14 (11) (2020)
Lan Zhang, Pan Li, Enjie Liu, Chenju Xing, Di Zhu, Jianying Zhang, Weiwei Wang, Guozhong Jiang
Prognostic value of a five-lncRNA signature in esophageal squamous cell carcinoma. Cancer cell international 20 (2020)

Guozhong Jiang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Guozhong Jiang